Filing Details

Accession Number:
0001415889-25-002626
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-01-31 21:35:16
Reporting Period:
2025-01-29
Accepted Time:
2025-01-31 21:35:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1604821 Natera Inc. NTRA Services-Medical Laboratories (8071) 010894487
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1646649 Jonathan Sheena C/O Natera, Inc.
13011 Mccallen Pass Building A Suite 100
Austin TX 78753
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2025-01-29 1,053 $165.87 260,104 No 4 S Direct
Common Stock Disposition 2025-01-29 1 $167.16 260,103 No 4 S Direct
Common Stock Disposition 2025-01-31 163 $176.60 259,940 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 44,782 Indirect By Caraluna 1 Trust
Common Stock 44,782 Indirect By Caraluna 2 Trust
Footnotes
  1. The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 26, 2024.
  2. The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 27, 2023.
  3. Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.